Latest Institutional Placement News

Pivotal Metals Limited has announced a C$2.6 million flow-through share offer targeting Canadian investors, aimed at funding critical minerals exploration in Quebec. The offer complements a concurrent institutional placement, underscoring the company’s aggressive growth strategy amid significant operational risks.

Arafura Rare Earths has successfully raised A$475 million through a two-tranche institutional placement, backed by major investors including Hancock Prospecting, to fund the development of its Nolans Project.

L1 Group Limited has announced a $330 million equity raising to fund expansion initiatives, including new investment strategies and potential acquisitions, following its recent merger with Platinum Asset Management.

Cash Converters has successfully completed the institutional component of a $25 million equity raising, positioning itself to acquire 29 franchise stores and expand its retail footprint.

Amplia Therapeutics reports encouraging interim results for narmafotinib in metastatic pancreatic cancer, alongside a successful capital raise and key patent allowance.

Lindian Resources secures official government confirmation that its Kangankunde Rare Earths Project is exempt from Malawi’s new raw mineral export ban, ensuring uninterrupted progress toward production.

Western Gold Resources reports promising early drilling results and a significant upgrade to its Gold Duke Project economics, supported by a $6.75 million capital raise to fund production.

An application to the Takeovers Panel questions the integrity of Maronan Metals’ recent $16 million placement and its share purchase plan, raising concerns about undisclosed relationships and share price manipulation.

Arafura Rare Earths has launched a major A$475 million placement alongside a A$50 million share purchase plan, significantly advancing funding for its Nolans Project and edging closer to a Final Investment Decision in early 2026.

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Centaurus Metals has achieved a major milestone with the granting of the Jaguar Nickel Sulphide Project mining lease and reported promising new copper-gold discoveries at its Boi Novo project, underpinning its growth ambitions in Brazil.

Syrah Resources reported resumed production at its Balama graphite mine and ongoing qualification delays at its Vidalia anode material facility, while US tariffs on Chinese graphite reshape global supply chains.